Use of Omega-3 Fatty Acids for Perinatal Depression

Completed · Phase 2 · Has a placebo group

Conditions studied: Depression, Depression, Postpartum

In brief

This study will evaluate the effectiveness of using omega-3 fatty acids to treat women with perinatal depression.

Key facts

Study ID

NCT00402389

Run by

University of Arizona

People needed

50

Starts

2004-06-01

Expected to finish

2006-01-01

Last updated by the study team

2013-03-29

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women who are pregnant (12 to 32 weeks gestation) or postpartum
• Meets criteria for a major depressive episode
• Scores a minimum of 9 on the Edinburgh Postnatal Depression scale
• Must be able to be treated on an outpatient basis

You may not qualify if…

• Known intolerance or allergy to omega-3 fatty acid or fish oil
• Presently taking antidepressant medication
• Currently using heparin or warfarin (compounds used to prevent blood from clotting)
• Presence of psychotic symptoms
• History of mania (abnormally elevated mood state) or hypomania (same as mania but occurs at a much lesser degree)
• Active suicidal ideation (desire to commit suicide)

Where it is running

• Women's Mental Health Program; University of Arizona; Department of Psychiatry — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.